Gastric Microbiota Beyond : An Emerging Critical Character in Gastric Carcinogenesis
Overview
Affiliations
Gastric cancer (GC) is one of the global leading causes of cancer death. The association between , which is a predominant risk factor for GC, with GC development has been well-studied. Recently, accumulating evidence has demonstrated the presence of a large population of microorganisms other than in the human stomach. Existing sequencing studies have revealed microbial compositional and functional alterations in patients with GC and highlighted a progressive shift in the gastric microbiota in gastric carcinogenesis with marked enrichments of oral or intestinal commensals. Moreover, using a combination of gastric bacterial signatures, GC patients could be significantly distinguished from patients with gastritis. These findings, therefore, emphasize the importance of a collective microbial community in gastric carcinogenesis. Here, we provide an overview of non- gastric microbes in gastric carcinogenesis. The molecular mechanisms of gastric microbes-related carcinogenesis and potential clinical applications of gastric microbiota as biomarkers of GC are also explored.
Fusobacterium nucleatum confirmed in gastric biopsies of patients without Helicobacter pylori.
Kamali N, Talebi Bezmin Abadi A, Rahimi F, Forootan M BMC Res Notes. 2025; 18(1):109.
PMID: 40069707 PMC: 11899000. DOI: 10.1186/s13104-025-07165-8.
Intratumoral Bacteria are Uncommon in Gastrointestinal Stromal Tumor.
Tardy K, Kwak H, Tieniber A, Mangold A, Perez J, Do K Ann Surg Oncol. 2024; 32(3):1504-1510.
PMID: 39578323 PMC: 11811456. DOI: 10.1245/s10434-024-16526-9.
Autoimmune gastritis studies and gastric cancer: True renaissance or bibliometric illusion.
Isakov V World J Gastroenterol. 2024; 30(32):3783-3790.
PMID: 39221066 PMC: 11362875. DOI: 10.3748/wjg.v30.i32.3783.
Nath A, Natarajan J Genomics Inform. 2024; 22(1):1.
PMID: 38907281 PMC: 11184957. DOI: 10.1186/s44342-024-00001-8.
Change in Diagnosis of Infection in the Treatment-Failure Era.
Spagnuolo R, Scarlata G, Paravati M, Abenavoli L, Luzza F Antibiotics (Basel). 2024; 13(4).
PMID: 38667033 PMC: 11047737. DOI: 10.3390/antibiotics13040357.